Literature DB >> 2185425

Human U2 snRNA can function in pre-mRNA splicing in yeast.

E O Shuster1, C Guthrie.   

Abstract

The removal of introns from messenger RNA precursors requires five small nuclear RNAs (snRNAs), contained within ribonucleoprotein particles (snRNPs), which complex with the pre-mRNA and other associated factors to form the spliceosome. In both yeast and mammals, the U2 snRNA base pairs with sequences surrounding the site of lariat formation. Binding of U2 snRNP to the highly degenerate branchpoint sequence in mammalian introns is absolutely dependent on an auxiliary protein, U2AF, which recognizes a polypyrimidine stretch adjacent to the 3' splice site. The absence of this sequence motif in yeast introns has strengthened arguments that the two systems are fundamentally different. Deletion analyses of the yeast U2 gene have confirmed that the highly conserved 5' domain is essential, although the adjacent approximately 950 nucleotides can be deleted without any phenotypic consequence. A 3'-terminal domain of approximately 100 nucleotides is also required for wild-type growth rates; the highly conserved terminal loop within this domain (loop IV) may provide specific binding contacts for two U2-specific snRNP proteins. We have replaced the single copy yeast U2 (yU2) gene with human U2 (hU2), expecting that weak or no complementation would provide an assay for cloning additional splicing factors, such as U2AF. We report here that hU2 can complement the yeast deletion with surprising efficiency. The interactions governing spliceosome assembly and intron recognition are thus more conserved than previously suspected. Paradoxically, the conserved loop IV sequence is dispensable in yeast.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185425     DOI: 10.1038/345270a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Identification of a U2/U6 helix la mutant that influences 3' splice site selection during nuclear pre-mRNA splicing.

Authors:  J S Chang; D S McPheeters
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

2.  A putative homolog of U2AF65 in S. cerevisiae.

Authors:  E Birney; S Kumar; A R Krainer
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

3.  Multiple functional domains of human U2 small nuclear RNA: strengthening conserved stem I can block splicing.

Authors:  J Wu; J L Manley
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

4.  Structure and assembly of the SF3a splicing factor complex of U2 snRNP.

Authors:  Pei-Chun Lin; Rui-Ming Xu
Journal:  EMBO J       Date:  2012-02-07       Impact factor: 11.598

5.  Cloning of mDEAH9, a putative RNA helicase and mammalian homologue of Saccharomyces cerevisiae splicing factor Prp43.

Authors:  S Gee; S W Krauss; E Miller; K Aoyagi; J Arenas; J G Conboy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

6.  Limited functional equivalence of phylogenetic variation in small nuclear RNA: yeast U2 RNA with altered branchpoint complementarity inhibits splicing and produces a dominant lethal phenotype.

Authors:  L Miraglia; S Seiwert; A H Igel; M Ares
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

7.  From the ribosome to the spliceosome and back again.

Authors:  Christine Guthrie
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

8.  RNA-Seq analysis identifies a novel set of editing substrates for human ADAR2 present in Saccharomyces cerevisiae.

Authors:  Tristan Eifler; Subhash Pokharel; Peter A Beal
Journal:  Biochemistry       Date:  2013-10-31       Impact factor: 3.162

9.  The yeast U2A'/U2B complex is required for pre-spliceosome formation.

Authors:  F Caspary; B Séraphin
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

10.  Identification and characterization of a yeast gene encoding the U2 small nuclear ribonucleoprotein particle B" protein.

Authors:  J Tang; N Abovich; M Rosbash
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.